Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02480881 · ClinicalTrials.gov registry record · Phase 1
A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)
A Phase 1 study, sponsored by ViiV Healthcare.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT02480881 is a Phase 1 study that has completed, run by ViiV Healthcare. The registered enrollment target is 26 participants.
The verdict
NCT02480881, a Phase 1 study, has completed, sponsored by ViiV Healthcare.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
This is an open-label, single sequence, 4-cycle, 4-treatment, drug-drug interaction (DDI) study in healthy female subjects on oral contraceptives (OC). There is no formal research hypothesis to be statistically tested. It is expected that coadministration of BMS-663068 with OC will not affect the pharmacokinetics (PK) of either ethinyl estradiol (EE) or norethindrone (NE).
Interventions
- DRUG BMS-663068
- DRUG Oral Contraceptive
- DRUG Loestrin 1.5/30
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2015-07-07 |
| Est. Completion | 2016-01-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02480881
The ClinicalTrials.gov registry entry for NCT02480881 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ViiV Healthcare, which has 182 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which BMS-663068 is the first listed.
NCT02480881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02480881 about?
NCT02480881 is a clinical study titled "A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)". This is an open-label, single sequence, 4-cycle, 4-treatment, drug-drug interaction (DDI) study in healthy female subjects on oral contraceptives (OC). There is no formal research hypothesis to be statistically tested. It is expected that coadministration of BMS-663068 with OC will not affect the ph...
What is the current status of trial NCT02480881?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2015-07-07. Estimated completion is 2016-01-11.
What interventions are being tested in trial NCT02480881?
The interventions under investigation include: BMS-663068 (DRUG), Oral Contraceptive (DRUG), Loestrin 1.5/30 (DRUG).
Who is sponsoring clinical trial NCT02480881?
This trial is sponsored by ViiV Healthcare, which has 182 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.